Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Pseudophakic cystoid macular edema: update 2016Clinical interventions in aging, 2016-01, Vol.11, p.1221-1229 [Peer Reviewed Journal]COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Grzybowski et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1178-1998 ;ISSN: 1176-9092 ;EISSN: 1178-1998 ;DOI: 10.2147/CIA.S111761 ;PMID: 27672316Full text available |
|
2 |
Material Type: Article
|
Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative ReviewClinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.1019-1045 [Peer Reviewed Journal]2022 Kishore et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Kishore et al. 2022 Kishore et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S209395 ;PMID: 35418744Full text available |
|
3 |
Material Type: Article
|
The Evolving Treatment of Diabetic RetinopathyClinical ophthalmology (Auckland, N.Z.), 2020-01, Vol.14, p.653-678 [Peer Reviewed Journal]2020 Mansour et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Mansour et al. 2020 Mansour et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/opth.s236637 ;PMID: 32184554Full text available |
|
4 |
Material Type: Article
|
Prevalence of Cystoid Macular Edema After Cataract Surgery in Eyes with Previous Macular SurgeryClinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.423-427 [Peer Reviewed Journal]2022 Padidam et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Padidam et al. 2022 Padidam et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S333754 ;PMID: 35210747Full text available |
|
5 |
Material Type: Article
|
Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical EndeavorClinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.661-669 [Peer Reviewed Journal]2021 Elfalah et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Elfalah et al. 2021 Elfalah et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S289068 ;PMID: 33628009Full text available |
|
6 |
Material Type: Article
|
Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edemaClinical ophthalmology (Auckland, N.Z.), 2013-01, Vol.7 (default), p.1423-1428 [Peer Reviewed Journal]2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Pacella et al, publisher and licensee Dove Medical Press Ltd 2013 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S48364 ;PMID: 23901252Full text available |
|
7 |
Material Type: Article
|
Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)Clinical ophthalmology (Auckland, N.Z.), 2017-01, Vol.11, p.393-401 [Peer Reviewed Journal]COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Blinder et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/opth.s128509 ;PMID: 28260851Full text available |
|
8 |
Material Type: Article
|
Faricimab for Treatment-Resistant Diabetic Macular EdemaClinical ophthalmology (Auckland, N.Z.), 2022-08, Vol.16, p.2797-2801 [Peer Reviewed Journal]COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Rush and Rush. 2022 Rush and Rush. ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S381503 ;PMID: 36042912Full text available |
|
9 |
Material Type: Article
|
Letter to the Editor Regarding the “Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The Constant Analysis” Article [Letter]Clinical ophthalmology (Auckland, N.Z.), 2020-11, Vol.14, p.3811-3812 [Peer Reviewed Journal]2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S286356Full text available |
|
10 |
Material Type: Article
|
Early Conversion to Aflibercept for Persistent Diabetic Macular Edema Results in Better Visual Outcomes and Lower Treatment CostsClinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.31-39 [Peer Reviewed Journal]2021 Ramsey et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Ramsey et al. 2021 Ramsey et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S286665 ;PMID: 33447009Full text available |
|
11 |
Material Type: Article
|
Brown-McLean syndrome: the role of iridodonesisClinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10 (Issue 1), p.671-677 [Peer Reviewed Journal]COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Suwan et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S96507 ;PMID: 27143844Full text available |
|
12 |
Material Type: Article
|
The Effect of Anti-Vascular Endothelial Growth Factor on Retinal Microvascular Changes in Diabetic Macular Edema Using Swept-Source Optical Coherence Tomography AngiographyClinical ophthalmology (Auckland, N.Z.), 2020-01, Vol.14, p.3871-3880 [Peer Reviewed Journal]2020 Pongsachareonnont et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Pongsachareonnont et al. 2020 Pongsachareonnont et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/opth.s270410 ;PMID: 33235428Full text available |
|
13 |
Material Type: Article
|
Role of Intravitreal Dexamethasone Implant in the Management of Treatment-Naive Diabetic Macular Edema: A Pre-Cataract Surgical Approach for Patients with Systemic Contraindications to Anti-VEGF TherapyClinical ophthalmology (Auckland, N.Z.), 2024-01, Vol.18, p.227-233 [Peer Reviewed Journal]2024 Chakraborty et al. ;COPYRIGHT 2024 Dove Medical Press Limited ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S449250 ;PMID: 38283181Full text available |
|
14 |
Material Type: Article
|
Treatment of Diabetic Macular Edema with Aflibercept and Micropulse Laser (DAM Study)Clinical ophthalmology (Auckland, N.Z.), 2022-04, Vol.16, p.1109-1115 [Peer Reviewed Journal]2022 Koushan et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Koushan et al. 2022 Koushan et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S360869 ;PMID: 35422607Full text available |
|
15 |
Material Type: Article
|
Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edemaClinical ophthalmology (Auckland, N.Z.), 2017-01, Vol.11, p.567-571 [Peer Reviewed Journal]COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Fouda and Bahgat. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S131381 ;PMID: 28356711Full text available |
|
16 |
Material Type: Article
|
Update on corticosteroids for diabetic macular edemaClinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10, p.1723-1730 [Peer Reviewed Journal]COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Schwartz et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S115546 ;PMID: 27660409Full text available |
|
17 |
Material Type: Article
|
Challenges in Diabetic Macular Edema Management: An Expert Consensus ReportClinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.3183-3195 [Peer Reviewed Journal]COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Udaondo et al. 2021 Udaondo et al. ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S320948 ;PMID: 34349495Full text available |
|
18 |
Material Type: Article
|
Integrated results from the COPERNICUS and GALILEO studiesClinical ophthalmology (Auckland, N.Z.), 2017-01, Vol.11, p.1533-1540 [Peer Reviewed Journal]COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Pielen et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/opth.s140665 ;PMID: 28883712Full text available |
|
19 |
Material Type: Article
|
Suprachoroidal versus Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular EdemaClinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.733-746 [Peer Reviewed Journal]2022 Zakaria et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Zakaria et al. 2022 Zakaria et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S351853 ;PMID: 35300032Full text available |
|
20 |
Material Type: Article
|
Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practiceClinical ophthalmology (Auckland, N.Z.), 2018-01, Vol.12, p.99-104 [Peer Reviewed Journal]COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Campos Polo et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S154421 ;PMID: 29386883Full text available |